Please login to the form below

ivabradine

This page shows the latest ivabradine news and features for those working in and with pharma, biotech and healthcare.

Amgen takes aim at cardio diseases with Arrowhead RNAi deal

Amgen is a recent entrant into the cardiovascular drugs arena, with recently-approved cholesterol-lowering drug Repatha (evolocumab) and heart failure drug Corlaner (ivabradine) spearheading its assault on the market.

Latest news

Amgen agrees to take Cytokinetics' heart failure drug into phase III

It sits among a new generation of heart failure therapies - spearheaded by Novartis' Entresto (sacubitril/valsartan) and Amgen/Servier's Corlanor (ivabradine) - which are trying to advance the treatment of heart
Shire and Baxalta drugs among CHMP's latest recommendations

ANPHARM Przedsiębiorstwo Farmaceutyczne's Ivabradine Anpharm (ivabradine) for the treatment of stable chronic angina pectoris and chronic heart failure.
Amgen starts shipping Corlaner in US

Corlaner (ivabradine) - the first new medicine for chronic heart failure in the US in almost a decade - will be available in pharmacies before the end of the week, according to
FDA clears Amgen's Corlaner for heart failure

The FDA approved Corlaner (ivabradine) after a priority review for reducing the risk of hospitalisation for worsening heart failure in patients with stable, symptomatic chronic heart failure (CHF). ... on ivabradine sales on the back of US approval and a
Amgen banking on three launches in 2015

year. These are evolocumab for high cholesterol, heart failure drug Corlaner (ivabradine) and talimogene laherparepvec (T-VEC) for melanoma.

More from news
Approximately 6 fully matching, plus 7 partially matching documents found.

Latest Intelligence

Heart failure therapy embarks on a new era

While Entresto has captured the headlines of late, there was another key development in HF therapy this year after Amgen secured approval in the US for Corlaner (ivabradine), a drug that ... Ivabradine is thought to be the first drug to work by
Deal Watch table for July 2013

100. ‡‡ Servier / Amgen . Cardiovascular collaboration, licence and option. Procoralan (ivabradine, approved), S38844 (p2), omecamtiv mecarbil (p2). ... Over 40 European countries, Australia, New Zealand . ‡ North America. ‡‡ Amgen receives
Pharma deals during July 2013

Under this agreement, Servier has granted Amgen US rights to Procoralan (ivabradine), which is approved in Europe for chronic heart failure and stable angina in patients with elevated heart rates.

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Featured jobs

Account Director: £48, 000 - £60, 000

Senior Medical Writer: Great salary and benefits

Project / Account Manager (Medical Education): Salary TBC

Consultant Health Economics - London / Oxford: Negotiable

SENIOR MEDICAL WRITER IN ONCOLOGY: Up to £60, 000.00 pension bonus

Account Director - Healthcare Advertising - London - HOME WORKIN...: £50000 - £68000

Scientific Director / Editorial Team Leader: Great salary and benefits

Senior Account Director development role to Business Director, H...: Excellent package

Senior Account Executive, London, Medical Communications: Excellent package

Chief Medical Writer, Medical Communications, London, up to £90K...: up to £90K

Medical Writer – Health Behaviour/ Patient Adherence Agency: Salary TBC

Account Manager- Healthcare Advertising: Negotiable

SAM – Health Behaviour/ Patient Adherence Healthcare Agency: Salary TBC

New Business Director - PR: Competitive Salary and benefits

Senior Account Managers - Oxfordshire: Attractive salary and benefits package offered

Account Manager, Healthcare Communications: £32, 000 - £40, 000 bonus benefits

Digital Manager, London – Healthcare Brandcomms, Medcomms, PR: Excellent package

Associate Director, Market Access & HEOR – North-West: Negotiable

Scientific Director – Medical Communications - New York or Remot...: $100000 - $150000

Principal Health Economist - North-West: Negotiable

Leadership opportunity, Pricing & Market Access, UK, Substan...: Substantial six figure package

Medical Writers: Competitive Salary and Benefits

Healthcare Advertising Senior Account Manager / AD / Senior AD: Salary TBC

Account Manager, Healthcare Public Affairs: £32, 000 – £40, 000 benefits

Client Services Director – Medical Education Agency – North West...: Salary TBC

Subscribe to our email news alerts

PMHub

Add my company

Attigo (part of the Mednet Group)

We are socially intuitive. Attigo deliver inspiring creative healthcare communications, whilst leading the way as partner of choice for socially-conscious...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award: The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
Artificial Intelligence in Healthcare: Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer: Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...